BioCentury | Mar 30, 2018
Finance

Bug money

...BioCentury’s analysis of VC-backed companies identified only one company with a disclosed bacteriophage lead program, Pherecydes Pharma S.A....
...NIAID), Bethesda, Md. National Institutes of Health, Bethesda, Md. National Research Center Canada, Ottawa, Ontario Pherecydes Pharma S.A....
BioCentury | Feb 9, 2018
Product R&D

Debugging the microbiome

...antibiotics that can overcome resistance to marketed therapies. Three of them -- AmpliPhi Biosciences Corp., Pherecydes Pharma S.A....
...Tokyo, Japan Keio University School of Medicine, Tokyo, Japan Massachusetts Institute of Technology, Cambridge, Mass. Pherecydes Pharma S.A....
BioCentury | Jan 19, 2018
Financial News

Pherecydes raises €8.7M series B

...Anti-infectives company Pherecydes Pharma S.A. (Romainville, France) raised €8.7 million ($10.6 million) in a series B round led...
...participated, along with existing investors ACE Management, Auriga Partners and Participations Besançon. Pherecydes Pharma S.A., Romainville, France Chris Lieu Pherecydes Pharma S.A....
BioCentury | Aug 31, 2017
Product R&D

Cutting through resistance

...and avoiding resistance. At least three companies -- AmpliPhi Biosciences Corp. , Intralytix Inc. and Pherecydes Pharma S.A....
...Baltimore, Md. Locus Biosciences Inc., Research Triangle Park, N.C. North Carolina State University, Raleigh, N.C. Pherecydes Pharma S.A....
BioCentury | Aug 3, 2017
Strategy

FDA's phage philosophy

...In addition to AmpliPhi, at least three other companies have phage products in the clinic. Pherecydes Pharma S.A....
...NIAID), Bethesda, Md. National Institutes of Health (NIH), Bethesda, Md. Panacea Pharmaceuticals Inc., Gaithersburg, Md. Pherecydes Pharma S.A....
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...customized to treat their infection, said Salka. Other companies developing phage cocktails include Intralytix and Pherecydes Pharma S.A....
...Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts Institute of Technology (MIT), Cambridge, Mass. Pherecydes Pharma S.A....
Items per page:
1 - 6 of 6
BioCentury | Mar 30, 2018
Finance

Bug money

...BioCentury’s analysis of VC-backed companies identified only one company with a disclosed bacteriophage lead program, Pherecydes Pharma S.A....
...NIAID), Bethesda, Md. National Institutes of Health, Bethesda, Md. National Research Center Canada, Ottawa, Ontario Pherecydes Pharma S.A....
BioCentury | Feb 9, 2018
Product R&D

Debugging the microbiome

...antibiotics that can overcome resistance to marketed therapies. Three of them -- AmpliPhi Biosciences Corp., Pherecydes Pharma S.A....
...Tokyo, Japan Keio University School of Medicine, Tokyo, Japan Massachusetts Institute of Technology, Cambridge, Mass. Pherecydes Pharma S.A....
BioCentury | Jan 19, 2018
Financial News

Pherecydes raises €8.7M series B

...Anti-infectives company Pherecydes Pharma S.A. (Romainville, France) raised €8.7 million ($10.6 million) in a series B round led...
...participated, along with existing investors ACE Management, Auriga Partners and Participations Besançon. Pherecydes Pharma S.A., Romainville, France Chris Lieu Pherecydes Pharma S.A....
BioCentury | Aug 31, 2017
Product R&D

Cutting through resistance

...and avoiding resistance. At least three companies -- AmpliPhi Biosciences Corp. , Intralytix Inc. and Pherecydes Pharma S.A....
...Baltimore, Md. Locus Biosciences Inc., Research Triangle Park, N.C. North Carolina State University, Raleigh, N.C. Pherecydes Pharma S.A....
BioCentury | Aug 3, 2017
Strategy

FDA's phage philosophy

...In addition to AmpliPhi, at least three other companies have phage products in the clinic. Pherecydes Pharma S.A....
...NIAID), Bethesda, Md. National Institutes of Health (NIH), Bethesda, Md. Panacea Pharmaceuticals Inc., Gaithersburg, Md. Pherecydes Pharma S.A....
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...customized to treat their infection, said Salka. Other companies developing phage cocktails include Intralytix and Pherecydes Pharma S.A....
...Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts Institute of Technology (MIT), Cambridge, Mass. Pherecydes Pharma S.A....
Items per page:
1 - 6 of 6